FDA Panel Conflict of Interest Waivers Would Be Barred Under House Bill
This article was originally published in The Tan Sheet
Executive Summary
FDA would effectively be barred from granting financial conflict of interest waivers for advisory committee members under the fiscal year 2006 House agriculture appropriations bill